ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today.

Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year.
For the full year of 2020, revenues are expected to be between $60-65 million.
[irp posts=”59928″]
____
Most Popular
Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform for independent pharmacies to operate efficiently. While expanding its customer
TTWO Earnings: Take-Two Interactive slips to a loss in Q1; revenue up 36%
Gaming company Take-Two Interactive Software, Inc. (NASDAQ: TTWO) announced first-quarter 2023 results Monday after the closing bell, reporting a 36% revenue growth. First-quarter revenues rose 36% annually to $1.1 billion
Tyson Foods (TSN): Strong demand for beef and price hikes in chicken fuel Q3 top line growth
Shares of Tyson Foods Inc. (NYSE: TSN) plunged 9% on Monday after the company delivered mixed results for the third quarter of 2022. Revenues beat estimates while profits missed expectations.